glutathione reduction biochemistry System from Cyanobacteria to Higher Eukaryotes Glutathione system enhancement for cardiac

Patel PC

Nature 414 , 799806 (2001)

Data in China showed that one in five patients with COVID-19 has myocardial necrosis (53), with an inflammation response and cytokine storm as possible mechanisms (54)

For patients with myocardial T2* 20 ms, DFX treatment can prevent myocardial iron accumulation and be accompanied by an increase in LVEF (128)

When present, side effects are typically mild and transient for each component: from DSIPslight drowsiness if administered too early (resolved by timing adjustment), mild headaches during initial adaptation in some individuals (usually resolving within days), or temporary vivid dreams as sleep architecture normalizes

Additionally, fenofibratealthough primarily used to manage dyslipidemiahas shown protective effects in DR patients in the FIELD and ACCORD-Eye trials, which are attributed in part to its anti-inflammatory and antioxidant properties independent of lipid lowering (154)